<?xml version="1.0" encoding="UTF-8"?>
<ref id="B95-antibiotics-10-00092">
 <label>95.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Peng</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Zhao</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Qiu</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Yang</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>H.</given-names>
   </name>
  </person-group>
  <article-title>Design, synthesis, and biological evaluation of 2-(phenoxyaryl)-3-urea derivatives as novel P2Y1 receptor antagonists</article-title>
  <source>Eur. J. Med. Chem.</source>
  <year>2018</year>
  <volume>158</volume>
  <fpage>302</fpage>
  <lpage>310</lpage>
  <pub-id pub-id-type="doi">10.1016/j.ejmech.2018.09.014</pub-id>
  <pub-id pub-id-type="pmid">30223118</pub-id>
 </element-citation>
</ref>
